These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30156054)

  • 21. [Clinical and genetic study patients with tuberous sclerosis complex].
    Rubilar C; López F; Troncoso M; Barrios A; Herrera L
    Rev Chil Pediatr; 2017 Feb; 88(1):41-49. PubMed ID: 28288225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
    Astrinidis A; Henske EP
    Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diagnosis of tuberous sclerosis complex in fetuses and infants: an institutional case series.
    Bolshakova AS; Maslennikov DN; Shubina J; Bystritskiy AA; Tolmacheva ER; Mukosey IS; Kochetkova TO; Vasiliev GS; Atapina EE; Sadelov IO; Zaretskaya NV; Barkov IY; Degtyarev DN; Trofimov DY
    J Clin Pathol; 2024 Oct; 77(11):756-760. PubMed ID: 37536923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of tuberous sclerosis complex in the fetus.
    Dragoumi P; O'Callaghan F; Zafeiriou DI
    Eur J Paediatr Neurol; 2018 Nov; 22(6):1027-1034. PubMed ID: 30279084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
    MacKeigan JP; Krueger DA
    Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis.
    Franz DN
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1181-92. PubMed ID: 21916571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel 23-base-pair duplication mutation in TSC1 exon 15 in an infant presenting with cardiac rhabdomyomas.
    Smith M; Sperling D
    Am J Med Genet; 1999 Jun; 84(4):346-9. PubMed ID: 10340649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants.
    Davis PE; Filip-Dhima R; Sideridis G; Peters JM; Au KS; Northrup H; Bebin EM; Wu JY; Krueger D; Sahin M;
    Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29101226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis of tuberous sclerosis complex focusing on prenatal period].
    Filipová H; Procházka M; Vrtěl R
    Ceska Gynekol; 2016 Apr; 81(2):147-54. PubMed ID: 27457398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberous sclerosis complex.
    Henske EP; Jóźwiak S; Kingswood JC; Sampson JR; Thiele EA
    Nat Rev Dis Primers; 2016 May; 2():16035. PubMed ID: 27226234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberous sclerosis complex and DNA repair.
    Habib SL
    Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL; Logginidou H; Klein-Szanto A; Henske EP
    Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central nervous system manifestations of tuberous sclerosis complex.
    Lu DS; Karas PJ; Krueger DA; Weiner HL
    Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):291-298. PubMed ID: 30230171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece.
    Avgeris S; Fostira F; Vagena A; Ninios Y; Delimitsou A; Vodicka R; Vrtel R; Youroukos S; Stravopodis DJ; Vlassi M; Astrinidis A; Yannoukakos D; Voutsinas GE
    Sci Rep; 2017 Dec; 7(1):16697. PubMed ID: 29196670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutation in the TSC2 gene associated with prenatally diagnosed cardiac rhabdomyomas and cerebral tuberous sclerosis.
    Chen CP; Su YN; Hung CC; Shih JC; Wang W
    J Formos Med Assoc; 2006 Jul; 105(7):599-603. PubMed ID: 16877242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex.
    Jeong A; Wong M
    Epilepsia; 2016 Sep; 57(9):1443-9. PubMed ID: 27417921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
    Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
    J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nursing implications for the lifelong management of tuberous sclerosis complex.
    Agricola K; Tudor C; Krueger D; Franz DN
    J Neurosci Nurs; 2013 Aug; 45(4):226-42. PubMed ID: 23812052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond.
    Henske EP
    Pediatr Nephrol; 2005 Jul; 20(7):854-7. PubMed ID: 15856327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.